Holistic Management of Grade 1 Osteoarthritis and Obesity in a 64-Year-Old Woman Through a Family Physician Approach
DOI:
https://doi.org/10.53089/medula.v12i1.422Keywords:
Family Physician, Osteoarthritis, Holistic ManagementAbstract
Osteoarthritis (OA) is a progressive degenerative joint disease characterized by damage to joint cartilage and diarthrodial joint structures. In Indonesia, OA is the most common rheumatic disease compared to other rheumatic diseases. The causes of OA are multifactorial, especially increasing at the age of 50 years, including gender, obesity, genetic and racial factors, family history, joint injury, strenuous physical activity and exercise habits, work, and repetitive joint use. The method used is study analysis. Primary data were obtained through history taking, physical examination and home visits to complete family data, psychosocial and environmental data. Assessment is carried out based on a holistic diagnosis from the beginning, process, and end of the study quantitatively and qualitatively. The patient is Mrs. P, 64 years old with a diagnosis of Osteoarthritis. Patients have internal risk aspects of lack of knowledge about OA, curative treatment patterns, irregular eating patterns. The external risk aspect for the patient is the lack of knowledge and family support in treatment. Furthermore, holistic management of patients and families is carried out through flipchart intervention media in the form of information about OA and recommended activities for patients, educating about simple physical exercises. In the evaluation, it was found that the patient's complaints were reduced, and they were willing to consume food with a good lifestyle and try regular exercise. Holistic management can improve knowledge, attitudes, and behavior in patients. In addition, the role of the family is very important in the care and treatment of patients and support is also needed
References
Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384(1):51-59.
Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. Jama. 2021;325(6):568-578.
Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology. 2018;57(suppl_4):iv51-iv60.
Roemer FW, Demehri S, Omoumi P, et al. State of the art: Imaging of osteoarthritis—Revisited 2020. Radiology. 2020;296(1):5-21.
Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin. 2020;104(2):293-311.
Ceballos-Laita L, Estébanez-de-Miguel E, Martín-Nieto G, Bueno-Gracia E, Fortún-Agúd M, Jiménez-del-Barrio S. Effects of non-pharmacological conservative treatment on pain, range of motion and physical function in patients with mild to moderate hip osteoarthritis. A systematic review. Complement Ther Med. 2019;42:214-222.
Mora JC, Przkora R, Cruz-Almeida Y. Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 2018;11:2189.
Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384(1):51-59.
Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. Jama. 2021;325(6):568-578.
Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology. 2018;57(suppl_4):iv51-iv60.
Roemer FW, Demehri S, Omoumi P, et al. State of the art: Imaging of osteoarthritis—Revisited 2020. Radiology. 2020;296(1):5-21.
Abramoff B, Caldera FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin. 2020;104(2):293-311.
Ceballos-Laita L, Estébanez-de-Miguel E, Martín-Nieto G, Bueno-Gracia E, Fortún-Agúd M, Jiménez-del-Barrio S. Effects of non-pharmacological conservative treatment on pain, range of motion and physical function in patients with mild to moderate hip osteoarthritis. A systematic review. Complement Ther Med. 2019;42:214-222.
Mora JC, Przkora R, Cruz-Almeida Y. Knee osteoarthritis: pathophysiology and current treatment modalities. J Pain Res. 2018;11:2189.
Oo WM, Little C, Duong V, Hunter DJ. The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date. Drug Des Devel Ther. 2021;15:2921.
de Wit M, Cooper C, Tugwell P, et al. Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res. 2019;31(7):905-915.
Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37(Suppl 120):3-6.
Hermann W, Lambova S, Muller-Ladner U. Current treatment options for osteoarthritis. Curr Rheumatol Rev. 2018;14(2):108-116.
Sartiwi W, Yanti E. CHARACTERISTICS AND PHYSICAL ACTIVITY WITH INCIDENCE OF OSTEOARTHRITIS IN HOSPITAL. In: Vol 1. ; 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.